Guideline Development Group
Chair: Graham Thornicroft, King’s College, London, United Kingdom.
Members: Abdullah Al-Khathami, Ministry of Health, Riyadh, Saudia Arabia; Christopher Dowrick, University of Liverpool, Liverpool, United Kingdom; Benjamin Druss, Emory University, Atlanta, USA; Rahib El Chammay, National Mental Health Programme, Beirut, Lebanon; Jacqueline Curtis, University of New South Wales, Sydney, Australia; Gail L. Daumit, Johns Hopkins University School of Medicine, Baltimore, USA; Christopher Dowrick, University of Liverpool, Institute of Psychology, Health and Society; Suhaila Ghuloum, Weill Cornell Medicine, Doha and Hamad Medical Corporation, Qatar; Oye Gureje, University College Hospital, Ibadan, Nigeria; Yueqin Huang, Peking University Institute of Mental Health, Beijing, China; Asma Humayun, Meditrina Healthcare, Islamabad, Pakistan; Mario Maj, University of Naples, Italy; Soontareeporn Meepring, Naresuan University, Bangkok, Thailand; Shanthi Mendis, Colombo, Sri Lanka; Thomas Munk Laursen, Aarhus University, Aarhus, Denmark; Dorairaj Prabhakaran, Public Health Foundation of India, New Delhi, India; Martin Prince, King’s College London, London, United Kingdom; Thara Rangaswamy, Schizophrenia Research Foundation, Chennai, India; David Shiers, Psychosis Research Unit, Greater Manchester Mental Health Trust, UK and Division of Psychology and Mental Health, University of Manchester, UK; Ezra Susser, Columbia University, New York, USA; Abebaw Fekadu Wassie, College of Health Sciences, Addis Ababa University, Ethiopia.
Grade methodologist: Corrado Barbui, University of Verona, Italy.
External review group: Atalay Alem, Department of Psychiatry, Faculty of Medicine, Addis Ababa University, Ethiopia; Zipporah Ali, Kenya Hospices and Palliative Care Association, Kenya; Lydia Chwastiak, University of Washington Medical Centre, USA; Alan Cohen, West London Mental Health Trust, UK; Pim Cuijpers, Virje University, Amsterdam, The Netherlands; Julian Eaton, London School of Hygiene and Tropical Medicine and CBM, UK; Alberto Minoletti, School of Public Health, Faculty of Medicine, University of Chile; Ayesha Motala, University of KwaZulu-Natal, South Africa; Rajat Ray, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India; Sarrafzadegan Nizal, Isfahan University of Medical Sciences in Iran and School of Population and Public Health in the University of British Columbia in Canada; John Saunders, The University of Sydney, Australia; Najma Siddiqi, University of York, UK; Isolde Sommers, Danube University Krems, Austria; Charlene Sunkel, Central Gauteng Mental Health Society, South Africa; Héðinn Unnsteinsson, Prime Minister’s Office, Iceland; Pieter Ventevogel, UNHCR, Switzerland Lakshmi Vijaykumar, Voluntary Health Services, Chennai, India; Inka Weissbecker, International Medical Corps, Washington DC, USA.
WHO Steering Group
Overall coordination: Tarun Dua, Programme Manager, Department of Mental Health and Substance Abuse; Neerja Chowdhary, Technical Officer, Department of Mental Health and Substance Abuse.
WHO headquarters members: Bernadette Cappello, Department of Essential Medicines and Health Products; Meg Doherty, Department of HIV/AIDS; Alexandra Fleischmann, Department of Mental Health and Substance Abuse; Dongbo Fu, Department of Prevention of Noncommunicable Diseases; Ernesto Jaramillo, Global TB Programme; Dzmitry Krupchanka; Department of Mental Health and Substance Abuse; Shanthi Pal, Department of Essential Medicines and Health Products; Vladimir Poznyak, Department of Mental Health and Substance Abuse; Shekhar Saxena, Department of Mental Health and Substance Abuse; Mark van Ommeren, Department of Mental Health and Substance Abuse; Cherian Varghese, Department of NCDs, Disability, Violence and Injury Prevention.
WHO regional office advisors: Nazneen Anwar, WHO Regional Office for South-East Asia; Dan Chisholm, WHO Regional Office for Europe; Devora Kestel, WHO Regional Office for the Americas; Sebastiana Da Gama Nkomo, WHO Regional Office for Africa; Khalid Saeed, WHO Regional Office for the Eastern Mediterranean; Martin Vandendyck, WHO Regional Office for the Western Pacific.
WHO evidence review and synthesis team: Jayati Das-Munshi, King’s College London, London, United Kingdom; Petra Gronholm, King’s College London, London, United Kingdom; Kavitha Kolappa, Harvard Medical School, Boston, USA; Maya Semrau, King’s College, London and Brighton and Sussex Medical School, UK.
We are grateful to the participants of the Excess Mortality in Severe Mental Disorders meeting, November 2015, for their contribution to the scoping process.
